Recombinant human erythropoietin (Daying Pharma)
重组人红细胞生成素（大鹰药业）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human erythropoietin (Daying Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2002/05/09
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDaying Pharmaceutical
China Registration ClassN/A
Develop Information
Other Information
ATC Code
Related LinksN/A